News – Page 534 – Endpoints News

Publicis hosts social health champion Chelsea Clinton on equity, politics and podcasting in healthcare

4 years ago

Senators grill Califf over proposed FDA budget as commissioner lays out 2023 priorities

4 years ago

Eli Lilly ends Q1 on a high note on the heels of positive obesity trial data

4 years ago

More program cuts ahead as Sanofi CEO Paul Hudson continues to reshape the company

4 years ago

Grand River Aseptic pulls in prize from government to expand home base; Irish Amcor site to expand as demand ...

4 years ago

Cannes Lions Health juries announced, pharma and health and wellness awards set for first day gala

4 years ago

Big Pharma CEOs assess the BD landscape in biotech: Albert Bourla is staying focused on 2025-2030

4 years ago

Montreal will be Moderna's next manufacturing venture — report

4 years ago

Y-mAbs' longtime CEO steps down abruptly as FDA reviews second pediatric cancer drug

4 years ago

Scoop: After failing to secure more funds, a private gene therapy developer lays off staff

4 years ago

Pfizer can restart PhIII trial of Duchenne gene therapy, now on track for late-2023 FDA approval request

4 years ago

More molecular glue: Plexium pens AbbVie pact months after Amgen deal

4 years ago

Aviv Regev recruits a ‘purple unicorn’ for the top post in the computational pillar she’s building at Genentech

4 years ago

Syncona-backed biotech launches in bid to shield heart cells from heart attacks

4 years ago

Moderna beats Pfizer to the punch, files EUA for Covid-19 vaccine for youngest children

4 years ago

BioMarin plots comeback year, with plans to turn around profits and head back to the FDA with rejected gene therapy

4 years ago

Eli Lilly throws down the gauntlet in obesity race, challenging Novo Nordisk with new PhIII readout

4 years ago

Gene therapy outfit emerges from stealth with big ambitions. First stop — CAR-T

4 years ago

IRS seeks more than $7B in back taxes and penalties from Amgen for shifting profits to Puerto Rico

4 years ago

Axovant-turned-Sio ditches two remaining programs, lays off most employees and will seek a buyer

4 years ago

One year later, US Trade Representative still supports an IP waiver for Covid-19 vaccines

4 years ago

Hundreds at NYU walk out in protest of reports that David Sabatini may join faculty

4 years ago

With a buyout, planned spinout and late-stage readouts, GSK promises this will be a landmark year

4 years ago

Publicis kicks off its HealthFront media event with CNN celebrity physician and health industry changes

4 years ago

First page Previous page 531 532 533534535 536 537 Next page Last page